151 related articles for article (PubMed ID: 36328137)
1. Dabigatran etexilate is efficacious in consumptive coagulopathy and pain associated with venous malformations.
Liu H; Hu L; Yang X; Xu Z; Gu H; Chen H; Lin X
J Vasc Surg Venous Lymphat Disord; 2023 Mar; 11(2):397-403.e1. PubMed ID: 36328137
[TBL] [Abstract][Full Text] [Related]
2. Dabigatran etexilate versus low-molecular weight heparin to control consumptive coagulopathy secondary to diffuse venous vascular malformations.
Ardillon L; Lambert C; Eeckhoudt S; Boon LM; Hermans C
Blood Coagul Fibrinolysis; 2016 Mar; 27(2):216-9. PubMed ID: 26484645
[TBL] [Abstract][Full Text] [Related]
3. Dabigatran etexilate in the treatment of localized intravascular coagulopathy associated with venous malformations.
Binet Q; Lambert C; Hermans C
Thromb Res; 2018 Aug; 168():114-120. PubMed ID: 30064682
[TBL] [Abstract][Full Text] [Related]
4. Association of localized intravascular coagulopathy with venous malformations.
Dompmartin A; Acher A; Thibon P; Tourbach S; Hermans C; Deneys V; Pocock B; Lequerrec A; Labbé D; Barrellier MT; Vanwijck R; Vikkula M; Boon LM
Arch Dermatol; 2008 Jul; 144(7):873-7. PubMed ID: 18645138
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and Safety of Treatment with Direct Oral Anticoagulant Rivaroxaban in Patients with Slow-Flow Vascular Malformations: A Case Series.
Mack JM; Richter GT; Crary SE
Lymphat Res Biol; 2018 Jun; 16(3):278-281. PubMed ID: 29583078
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment with dabigatran for consumptive coagulopathy associated with extensive vascular malformations.
Yasumoto A; Ishiura R; Narushima M; Yatomi Y
Blood Coagul Fibrinolysis; 2017 Dec; 28(8):670-674. PubMed ID: 28938309
[TBL] [Abstract][Full Text] [Related]
7. Coagulopathy and related complications following sclerotherapy of congenital venous malformations.
Swerdlin RF; Briones MA; Gill AE; Hawkins CM
Pediatr Blood Cancer; 2022 May; 69(5):e29610. PubMed ID: 35234344
[TBL] [Abstract][Full Text] [Related]
8. Venous malformations with severe localized intravascular coagulopathy treated with microwave ablation.
Tai MZ; Wang YP; Chen T; Li KL; Xu ZG; Ge CX; Qin ZP; Zheng JW
Vascular; 2022 Aug; 30(4):779-786. PubMed ID: 34144653
[TBL] [Abstract][Full Text] [Related]
9. MRI phenotypes of localized intravascular coagulopathy in venous malformations.
Koo KS; Dowd CF; Mathes EF; Rosbe KW; Hoffman WY; Frieden IJ; Hess CP
Pediatr Radiol; 2015 Oct; 45(11):1690-5. PubMed ID: 26143286
[TBL] [Abstract][Full Text] [Related]
10. D-dimer level correlation with treatment response in children with venous malformations.
Leung YC; Leung MW; Yam SD; Hung JW; Liu CS; Chung LY; Tang MY; Fung HS; Poon WL; Chao NS; Liu KK
J Pediatr Surg; 2018 Feb; 53(2):289-292. PubMed ID: 29221638
[TBL] [Abstract][Full Text] [Related]
11. Rivaroxaban for the treatment of consumptive coagulopathy associated with a vascular malformation.
Vandenbriele C; Vanassche T; Peetermans M; Verhamme P; Peerlinck K
J Thromb Thrombolysis; 2014 Jul; 38(1):121-3. PubMed ID: 24202701
[TBL] [Abstract][Full Text] [Related]
12. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and Pharmacodynamics of the Nonvitamin K Antagonist Oral Anticoagulant Edoxaban When Administered Alone or After Switching from Rivaroxaban or Dabigatran Etexilate in Healthy Subjects.
Parasrampuria DA; Weilert D; Maa JF; Dishy V; Kochan J; Shi M; Brown KS
Clin Drug Investig; 2016 Feb; 36(2):127-36. PubMed ID: 26597179
[TBL] [Abstract][Full Text] [Related]
14. Localised intravascular coagulation complicating venous malformations: Clinical characterisation.
Blaise S; Soya E; Nou M; Malloizel-Delaunay J; Thiel H; Bisdorff-Bresson A; Seinturier C
Phlebology; 2024 Apr; 39(3):169-173. PubMed ID: 37978831
[TBL] [Abstract][Full Text] [Related]
15. Dabigatran etexilate: a review of its use for the prevention of venous thromboembolism after total hip or knee replacement surgery.
Burness CB; McKeage K
Drugs; 2012 May; 72(7):963-86. PubMed ID: 22564134
[TBL] [Abstract][Full Text] [Related]
16. Effect of sirolimus on coagulopathy of slow-flow vascular malformations.
Mack JM; Verkamp B; Richter GT; Nicholas R; Stewart K; Crary SE
Pediatr Blood Cancer; 2019 Oct; 66(10):e27896. PubMed ID: 31250546
[TBL] [Abstract][Full Text] [Related]
17. A novel coagulation parameter monitoring bleeding tendency of Chinese nonvalvular atrial fibrillation patients prescribing dabigatran etexilate.
Wang H; Zhou Y; Rong G; Lu L; Zhang J
Blood Coagul Fibrinolysis; 2016 Jul; 27(5):563-7. PubMed ID: 26881855
[TBL] [Abstract][Full Text] [Related]
18. Venous Malformation and Localized Intravascular Coagulopathy in Children.
Hung JW; Leung MW; Liu CS; Fung DH; Poon WL; Yam FS; Leung YC; Chung KL; Tang PM; Chao NS; Liu KK
Eur J Pediatr Surg; 2017 Apr; 27(2):181-184. PubMed ID: 27089461
[No Abstract] [Full Text] [Related]
19. Phase IIa study of dabigatran etexilate in children with venous thrombosis: pharmacokinetics, safety, and tolerability.
Halton JML; Albisetti M; Biss B; Bomgaars L; Brueckmann M; Gropper S; Harper R; Huang F; Luciani M; Maas H; Tartakovsky I; Mitchell LG
J Thromb Haemost; 2017 Nov; 15(11):2147-2157. PubMed ID: 28921890
[TBL] [Abstract][Full Text] [Related]
20. Localised intravascular coagulation complicating venous malformations in children: Associations and therapeutic options.
Zhuo KY; Russell S; Wargon O; Adams S
J Paediatr Child Health; 2017 Aug; 53(8):737-741. PubMed ID: 28169477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
